Related Experiment Video

Updated: Feb 18, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.2K

The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases

Keiran S M Smalley1, Peter A Forsyth2

  • 1The Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA; The Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.

Pharmacological Research
|November 18, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.4K

Related Experiment Videos

Last Updated: Feb 18, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.2K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.4K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

53.6K
Overview
53.6K

Articles linked to this work by shared authors, journal, and citation graph.

GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma.

Cancer research·2026

Breaking barriers in leptomeningeal disease: A Society for Neuro-Oncology and The American Society of Clinical Oncology consensus review on clinical trial design and basic science integration.

Neuro-oncology·2026

A New Era in Leptomeningeal Disease (LMD): Recent Advancements in Immunocellular and Radiation Therapies in Melanoma LMD, What Has Been Done and Future Directions.

Pigment cell & melanoma research·2026

A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma.

Cancer research·2026

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Modulation of Spliceosomal Proteins hnRNPH1 and H2 Increases Melanoma Cell Pro-Inflammatory Signaling In Vitro.

Biomolecules·2025

Mitochondrial Transplantation as a Therapeutic Strategy: From Energy Replacement to Metabolic and Immune Reprogramming.

Pharmacological research·2026

MAMDC2 drives microglia-mediated neuroinflammation via CAND1-dependent IκBα ubiquitination and is targetable by Artemvulactone E.

Pharmacological research·2026

The dual role of BDNF in epilepsy: insights from calpain-mediated TrkB-FL cleavage.

Pharmacological research·2026

Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling.

Pharmacological research·2026

GABARAPL1 drives therapeutic differentiation of cancer cells by targeting epigenetic changes regulated by SFPQ.

Pharmacological research·2026

Redox imbalance and epigenetic reprogramming underlie polysubstance-induced neuronal dysfunction.

Pharmacological research·2026

Phyto-Mediated Synthesized Gold Nanoparticles (AuNPs) from Ozoroa paniculosa Leaf Extracts: Chemical Characterization and Antidiabetic Evaluation.

Pharmaceuticals (Basel, Switzerland)·2026

Ultrasound Shear-Wave and Strain Elastography for Differentiating Morton's Neuroma from Intermetatarsal Bursitis.

Life (Basel, Switzerland)·2026

Middle Meningeal Artery Embolization Using Non-Adhesive Liquid Embolic Agents for Chronic Resistant Migraine: Interim Feasibility and Safety Analysis of a Prospective Single-Arm Trial.

Journal of clinical medicine·2026

Noninvasive Neuromodulation for Cognitive Dysfunction in Parkinson's Disease: A Scoping Review.

Brain sciences·2026

Bing-Neel syndrome successfully treated with venetoclax and zanubrutinib: A case report and review of the literature.

Medicine·2026

In Vivo Blood Kinetics and Transcript Integrity of Three mRNA-Lipid Nanoparticle Vaccines in Humans.

ACS nano·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us